Live 5 updates · Last at 4:18pm ET Updates appear automatically.

Live: Can UiPath’s Q2 Earnings Tonight Extend Its 40% Rally in Just One Month?

By Thomas Richmond · Updated Sep 3, 4:18pm ET · Published Sep 3, 3:27pm ET

Live Updates

Newest first

UiPath Q2 Earnings Are Out - Stock Soars 12% on Results

UiPath just reported earnings, with shares initially up 12% following the report. Here are the key numbers:

  • Revenue: $410.26M vs. $397.85M expected
  • Adjusted EPS: $0.15 vs. $0.15 expected

Quick Read:

UiPath beat revenue expectations by roughly 3% while adjusted EPS came in exactly in line with Wall Street estimates.

The 12% initial surge suggests investors like the top-line momentum, with revenue growing 13% year over year as Wall Street looks for evidence that UiPath’s agentic AI strategy is accelerating growth.

UiPath's Q2 Bull vs Bear Case After a 40% 1-Month Rally

Bull Case: Momentum, Margins, and Agentic Traction

  • Consistent revenue beats: Q2 FY26 by 4.14%, Q3 FY26 by 4.64%, Q4 FY26 by 3.51%, Q1 FY27 by 5.26%, with Q1 revenue of $418 million, up 17%.
  • 16 of the top 20 deals included AI, and AI expansion deals ran six times larger.
  • GAAP profitability arrived for the first time, with Q1 non-GAAP operating margin at 22%.
  • EPS revisions skew positive: 10 upward vs. 5 downward in 30 days.

Bear Case: High Bar, Decelerating Growth

  • Shares are up 37.85% in one month, raising the setup risk.
  • ARR growth is stuck near 11%-12%, well below prior levels.
  • Q1 EPS missed by 5.48%, and analysts remain 16 Hold vs. 3 Buy.
  • Insider direction is selling, an odd counterpoint to the rally.

Analysts' Top 5 Questions for UiPath Ahead of Tonight's Q2 Earnings

With UiPath (NYSE:PATH) reporting after the close, here is what to listen for on the 5:00 PM ET call.

Top 5 Analyst Questions

  1. Is net new ARR reaccelerating above the $49 million posted in Q1?
  2. How much is agentic AI contributing, given 16 of the top 20 deals already include it?
  3. Path to the 30% long-term non-GAAP margin target?
  4. Competitive wins versus Microsoft Power Automate and Salesforce Agentforce?
  5. Pace of buybacks after $243.8M repurchased in Q1?

Key Topics and Buzzwords

  • Maestro Case, UiPath for Coding Agents, WorkFusion contribution, outcome-based pricing.
  • Listen for “orchestration,” “deterministic plus agentic,” “pilot to production.”

Red Flags

  • ARR at the low end of $1.929B-$1.934B.
  • DBNR slipping below 109%.
  • Any full-year guide trim versus the $1.776B-$1.781B range, which would jeopardize the 37.85% one-month rally.

Insiders Have Been Selling Ahead of UiPath's Q2 Earnings

Insider Activity Scorecard

Date Insider Title Transaction Shares Price
2026-08-19 Daniel Dines CEO & Chairman Sell 1,402,347 $16.07
2026-08-14 Hitesh Ramani Chief Accounting Officer Sell 25,000 $16.75
2026-08-13 Hitesh Ramani Chief Accounting Officer Sell 25,000 $16.50
2026-07-01 Ashim Gupta COO & CFO Sell 30,526 $10.87
2026-07-01 Raghavendra Malpani CPO & CTO Sell 25,837 $10.87

Insider activity at UiPath (NYSE:PATH) over the past 90 days skewed decisively toward selling.

  • CEO Daniel Dines’ August 19 disposal of over 1.4 million shares dwarfed every other filing.
  • Chief Accounting Officer Hitesh Ramani added back-to-back sales in the mid-$16s.
  • July 1 dispositions from Gupta, Malpani, and Legal Chief Brad Brubaker at $10.87 appear tied to vesting.

The only acquisitions were six identical 19,175-share director grants on June 25 at $0.00, reflecting equity awards rather than open-market conviction. Dashboard data confirms net insider direction is selling.

With shares up 37.85% in a month, executives leaned into strength rather than adding exposure ahead of tonight’s earnings report, a caution flag against the setup.

UiPath Q2 Earnings Tonight: Can Agentic AI Justify the Stock's 40% 1-Month Rally?

UiPath is expected to report fiscal Q2 2027 earnings at 4:10 PM ET, with Wall Street looking for evidence that its agentic AI push is translating into stronger recurring revenue growth.

Management has guided for revenue of $395-$400 million and ARR between roughly $1.929-$1.934 billion. Investors will also be watching net new ARR, with a figure above roughly $49 million providing another signal that growth is accelerating.

The stakes are high after UiPath shares soared around 40% over the past month. A higher full-year ARR outlook could validate the rally and strengthen the case that UiPath is evolving from a traditional automation vendor into a broader enterprise AI orchestration platform.

A guidance cut would tell a very different story and could put much of the stock’s recent rally at risk.

This article is updated throughout the trading day. Check back for more.

Full Coverage

The story so far

UiPath (NYSE:PATH | PATH Price Prediction) is expected to report Q2 FY2027 results after the bell at 4:10 PM ET. Shares enter the report tonight at about $18.52, up around 65.05% over the past year on rising evidence that agentic AI is moving from pilot to production.

PATH price target

Momentum Meets a Higher Bar

Q1 FY27 delivered revenue of $418.38M, up 17.3% YoY, beating consensus by 5.26%, while adjusted EPS of $0.15 came in 5.48% shy of estimates. ARR grew 12% YoY to $1.901B on $49M of net new ARR, and dollar-based net retention ticked up to 109% from 107%.

Non-GAAP operating margin expanded to 22% from 20%, and stock-based compensation dropped to $53.3M from $76.4M. Management raised the FY27 non-GAAP operating income target to ~$430M and repurchased $243.8M of Class A stock. With PATH up over 40% in the past month, the setup rewards execution and punishes any ARR softness.

Consensus Estimates

Metric Q2 FY27 Estimate YoY Change FY2027 Estimate FY2028 Estimate
Revenue $397.85M +14.5% $1.778B $1.928B
EPS (Normalized) $0.1474 +76.7% $0.7828 $0.9066

FY27 revenue growth is modeled near 10.4%, a step down from FY26’s 12.65%. FY28 revenue growth of 8.4% pairs with EPS growth of 15.8%, consistent with continued margin leverage. The Q2 EPS consensus has held flat at $0.1474 across the last 60 days, with 10 upward revisions in the past week.

What I’m Watching Tonight: ARR, Margins, and Agentic AI

Tonight, I’ll be watching the ARR results against the $1.929B-$1.934B guide. Net new ARR needs to hold or exceed $49M to keep the stabilization-to-reacceleration thesis intact. On revenue mix, 16 of the top 20 Q1 deals included AI, and AI-inclusive expansions ran six times larger than those without. It would be great to see that continue to expand.

Analysts will also focus on dollar-based net retention. It moved 108% to 107% to 107% to 109% across the last four quarters. A result above 109% validates the reacceleration narrative CEO Daniel Dines flagged on the last call.

Non-GAAP operating margin was 22% in Q1 and 31% in Q4 FY26. Guidance implies compression this quarter, so investors will focus on whether spend on coding agents, Test Cloud, and forward-deployed engineering is moving progress toward the 30% long-term target.

Also on the list: traction for UiPath for Coding Agents, the Deloitte Agentic ERP alliance, and Maestro Case orchestration momentum. Guidance credibility is the tiebreaker after Q4 FY26’s cautious FY27 outlook sent shares -8.16% the next day.

Earnings History

Quarter EPS Surprise 1-Day Move 7-Day Move 30-Day Move
Q1 FY27 -5.48% +1.21% +0.78% -6.13%
Q4 FY26 +17.74% -8.16% +0.57% -18.26%
Q3 FY26 +9.59% +24.36% +25.77% +16.62%
Q2 FY26 +79.86% +5.90% +7.74% +33.82%
PATH earnings explorer

On average, shares moved 8.88% seven days after earnings over the past year.

Contact [email protected] for any questions or corrections.

Thomas Richmond

Thomas Richmond is a financial writer and content strategist with 5+ years of experience covering stocks and financial markets. He has published over 250 articles focused on individual stock analysis, helping investors better understand business fundamentals, stock valuations, and long-term opportunities.

Thomas previously served as a Content Lead at TIKR, a stock research platform, where he helped scale the company’s blog to hundreds of articles per month and contributed to a weekly newsletter reaching more than 100,000 investors.

He specializes in breaking down complex companies into clear, actionable insights for everyday investors, with a focus on fundamentals-driven research.

His work has also been featured on platforms including Seeking Alpha and Sure Dividend.

Outside of work, Thomas enjoys weight lifting and soccer.

All articles →